Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the pharmacokinetics of a single dose of intravenous or oral omadacycline in children and adolescents with suspected or confirmed bacterial infections.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Paratek Pharmaceuticals Inc
NCT06704048 · Infective Endocarditis, Bacterial Infections, and more
NCT04263792 · Bacterial Infections
NCT06135350 · Gram Negative Pneumonia, Gram-Negative Bacterial Infections, and more
NCT06103500 · Sepsis, Bacterial Infections, and more
NCT02979951 · Bacterial Infections, Bone Diseases, Infectious, and more
Site 109
Little Rock, Arkansas
Site 112
Long Beach, California
Site 107
Orange, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions